
CT-707 (Conteltinib) is a novel multikinase ингибитор targeting FAK (IC50=1.6 nM), ALK and Pyk2, exerts synergistic antitumor effects against hepatocellular carcinoma in vitro and in vivo.
CT-707 (Conteltinib) is a novel multikinase inhibitor targeting FAK (IC50=1.6 nM), ALK and Pyk2, exerts synergistic antitumor effects against hepatocellular carcinoma in vitro and in vivo.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.